MDS, Karpov Institute to study Mo-99 supply

MDS Nordion and the Karpov Institute of Physical Chemistry in Moscow have agreed to study the feasibility of the institute providing the firm with a supply of molybdenum-99 (Mo-99) for the global nuclear medicine market.

Under the collaboration, MDS Nordion and the Karpov Institute will combine their respective expertise and resources to explore a commercialization plan for a long-term supply of Mo-99, according to MDS Nordion of Ottawa, Canada.

Related Reading

MDS urges Canada to restart Maple reactor project, June 12, 2009

Facing Mo-99 shortage, nuclear medicine economizes, June 11, 2009

MDS posts loss in Q2 results, June 11, 2009

MDS begins CardioGen-82 production, June 10, 2009

MDS advocates Maple reactor activation, June 1, 2009

Copyright © 2009 AuntMinnie.com

Page 1 of 1262
Next Page